Basic info
Industry
pharmaceutical manufacturing
Sectors
Research and Development
Tyrosinemia
MS
Patient centric
Rare Diseases
Pharmaceutical
HAE
Multiple Sclerosis
Formulation technology
Neurology
Innovation
Pharmaceutical Industry
PKU
immunology
Date founded
2012
Funding rounds raised
Total raised
$25M
from 1 investors over 1 rounds
C
Cycle Pharmaceuticals raised $25M on September 7, 2020
Investors: Deutsche Bank